Does BCG revaccination lead to enhanced protective immunity against tuberculosis? A study using surrogate markers

H. Fjallbrant, L. O. Larsson, M. Ridell (Gothenburg, Stockholm, Sweden)

Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI
Session: Epidemiology and control of tuberculosis and LTBI
Session type: Oral Presentation
Number: 3143
Disease area: Respiratory infections

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Fjallbrant, L. O. Larsson, M. Ridell (Gothenburg, Stockholm, Sweden). Does BCG revaccination lead to enhanced protective immunity against tuberculosis? A study using surrogate markers. Eur Respir J 2005; 26: Suppl. 49, 3143

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
State of the art in vaccine development against TB
Source: Eur Respir Mon 2012; 58: 59-71
Year: 2012


Do antimicrobial peptides shape the adaptive immune response?
Source: Annual Congress 2005 - Interaction between innate and adaptive immunity in lung disease
Year: 2005

Pneumococcal and influenza vaccination
Source: Respipedia Article
Year: 2018

A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009

IgG-mediated humoral immune response against different mycobacterial antigens in tuberculosis (TB) and mycobacterial infections other than tuberculosis (MOTT)
Source: Eur Respir J 2001; 18: Suppl. 33, 307s
Year: 2001

Relationship between the whole blood interferon-gamma responses and the risk of active tuberculosis
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006


BCG vaccination in childhood is not related to pulmonary immunity against M. tuberculosis in adults
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014



Early BCG vaccination is unrelated to pulmonary immunity against Mycobacterium tuberculosis in adults
Source: Eur Respir J 2014; 44: 1087-1090
Year: 2014


Humoral immune response to influenza vaccination in silicosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 695s
Year: 2006

Humoral immune response against 38-kDa and 16-kDa mycobacterial antigens in tuberculosis
Source: Eur Respir J 2007; 29: 143-148
Year: 2007



Mucosal immunity and novel vaccines against tuberculosis
Source: Lung Science Conference 2015
Year: 2015

The status of populations of cell-mediated lung immunity effectors after chemotherapy of experimental MDR tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 656s
Year: 2005

TB in children
Source: Eur Respir Mon 2012; 58: 206-218
Year: 2012


MAIT cells contribute to a protective antiviral innate response to influenza infection
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018




The humoral immune response to influenza vaccination in lung transplant patients
Source: Eur Respir J 2001; 18: 971-976
Year: 2001



The protective effect of BCG vaccination against mycobacterium tuberculosis infection in children: A systematic review
Source: International Congress 2014 – Tuberculosis: public health and primary prevention
Year: 2014


Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test
Source: Eur Respir J 2006; 28: 16-23
Year: 2006



In vitro immune response to Mycobacterium tuberculosis antigens
Source: Eur Respir J 2005; 26: Suppl. 49, 22s
Year: 2005

Monitoring T-cell immunity towards M. tuberculosis: impaired specific immunocompetence in patients receiving high levels of immunosuppressive drugs
Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis
Year: 2008


LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
Source: Eur Respir J 2009; 33: 956-973
Year: 2009